Remotely Monitored Transcranial Direct Current Stimulation in Children With Cerebral Palsy

Status: Completed
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will explore using remotely monitored 'active' non-invasive brain stimulation in children with cerebral palsy. Participants will receive active non-invasive brain stimulation with synchronous safety monitoring and guided instruction with laboratory staff after appropriate training. Participants will be between 8-21 years old and have a diagnosis of hemiparetic cerebral palsy with a history of a perinatal stroke or brain bleed, and can expect to be in the study for 5 days.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 8
Maximum Age: 21
Healthy Volunteers: f
View:

• Aged between 8 years 0 days and 21 years 365 days

• Children who have hemiparetic cerebral palsy with a history of perinatal brain bleed/stroke

• Receptive language function to follow two-step commands

• Able to give informed assent along with the informed consent of the legal guardian. If the participant is 18-21 (with the capacity to consent), they must be able to give informed consent.

• Intentional about representing the sub-population of children with CP who experience intellectual disability (at least 2/10 participants with mild intellectual disabilities will be recruited)

• ≥ 10 degrees of active motion at the metacarpophalangeal joint

• Children who have had surgeries, which may influence motor function e.g.- tendon transfer, will be included, yet surgical history will be documented and included in any publication within a participant characteristics table.

Locations
United States
Wisconsin
University of Wisconsin
Madison
Time Frame
Start Date: 2022-12-21
Completion Date: 2023-06-06
Participants
Target number of participants: 10
Treatments
Experimental: Children diagnosed with stroke/brain bleed
Male and females aged 8 to 21 with established diagnosis of stroke/brain bleed who are US residents.
Related Therapeutic Areas
Sponsors
Leads: University of Wisconsin, Madison

This content was sourced from clinicaltrials.gov